[go: up one dir, main page]

PL1883392T3 - Sposób wytwarzania izotonicznego wodnego roztworu iniekcyjnego ropiwakainy - Google Patents

Sposób wytwarzania izotonicznego wodnego roztworu iniekcyjnego ropiwakainy

Info

Publication number
PL1883392T3
PL1883392T3 PL06770886T PL06770886T PL1883392T3 PL 1883392 T3 PL1883392 T3 PL 1883392T3 PL 06770886 T PL06770886 T PL 06770886T PL 06770886 T PL06770886 T PL 06770886T PL 1883392 T3 PL1883392 T3 PL 1883392T3
Authority
PL
Poland
Prior art keywords
ropivacaine
preparation
aqueous injection
isotonic aqueous
base
Prior art date
Application number
PL06770886T
Other languages
English (en)
Inventor
Christopher N Jobdevairakkam
Jagadeesh B Rangisetty
Original Assignee
Navinta Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37027513&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1883392(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Navinta Llc filed Critical Navinta Llc
Publication of PL1883392T3 publication Critical patent/PL1883392T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
PL06770886T 2005-05-25 2006-05-22 Sposób wytwarzania izotonicznego wodnego roztworu iniekcyjnego ropiwakainy PL1883392T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/137,256 US20060270708A1 (en) 2005-05-25 2005-05-25 Novel process for preparation of isotonic aqueous injection of ropivacaine
PCT/US2006/019804 WO2006127639A2 (en) 2005-05-25 2006-05-22 Process for preparation of isotonic aqueous injection of ropivacaine
EP06770886A EP1883392B1 (en) 2005-05-25 2006-05-22 Process for preparation of isotonic aqueous injection of ropivacaine

Publications (1)

Publication Number Publication Date
PL1883392T3 true PL1883392T3 (pl) 2011-07-29

Family

ID=37027513

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06770886T PL1883392T3 (pl) 2005-05-25 2006-05-22 Sposób wytwarzania izotonicznego wodnego roztworu iniekcyjnego ropiwakainy

Country Status (14)

Country Link
US (1) US20060270708A1 (pl)
EP (1) EP1883392B1 (pl)
JP (1) JP2008545694A (pl)
AT (1) ATE492269T1 (pl)
AU (1) AU2006251583A1 (pl)
CA (1) CA2608730A1 (pl)
CY (1) CY1111445T1 (pl)
DE (1) DE602006019085D1 (pl)
DK (1) DK1883392T3 (pl)
ES (1) ES2358884T3 (pl)
PL (1) PL1883392T3 (pl)
PT (1) PT1883392E (pl)
SI (1) SI1883392T1 (pl)
WO (1) WO2006127639A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20051144A1 (it) * 2005-06-17 2006-12-18 Molteni & C Dei Fratellei Alit "procedimento per la preparazione d'una soluzione iniettabile di (2s)-n-(2;6-dimetil-fenil)-1-propil-2-piperidincarbossiamide"
CN102697708A (zh) * 2012-04-17 2012-10-03 上海禾丰制药有限公司 盐酸罗哌卡因注射液及其制剂工艺
US11224593B2 (en) * 2015-07-13 2022-01-18 Neon Laboratories Limited Hyperbaric injection solution of ropivacaine hydrochloride and process for preparation thereof
CN105816432B (zh) * 2016-03-24 2020-02-07 成都天台山制药有限公司 注射用冷冻干燥盐酸罗哌卡因组合物及其质量控制方法
CN106177970B (zh) * 2016-07-12 2019-09-17 扬子江药业集团有限公司 罗哌卡因注射用制剂及其制备方法和应用
KR20200018438A (ko) * 2017-05-11 2020-02-19 스테디메드 리미티드 향상된 용해도의 약물-함유 제형

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2797241A (en) * 1953-08-28 1957-06-25 Brown Charles Leslie Meredith Diethyl-glycinexylidide and process
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
US6156900A (en) * 1994-10-07 2000-12-05 Darwin Discovery Limited Racemization of precursors to levobupivacaine and analogues thereof
DK0788481T3 (da) * 1994-10-25 2003-12-01 Darwin Discovery Ltd Fremgangsmåde til fremstilling af levobupivacain og analoger deraf
SE9501808D0 (sv) * 1995-05-16 1995-05-16 Astra Ab New process
ATE251893T1 (de) * 1996-01-25 2003-11-15 Schering Ag Verbesserte kontrastmittenlösungen für die intravasale anwendung
US6248345B1 (en) * 1997-07-02 2001-06-19 Euro-Celtique, S.A. Prolonged anesthesia in joints and body spaces
CA2308495C (en) * 1997-11-19 2009-01-06 Darwin Discovery Limited Anaesthetic formulation
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US7247729B2 (en) * 2001-09-10 2007-07-24 Mercian Corporation Method for producing pipecolamide derivative

Also Published As

Publication number Publication date
AU2006251583A1 (en) 2006-11-30
DE602006019085D1 (de) 2011-02-03
CA2608730A1 (en) 2006-11-30
EP1883392A2 (en) 2008-02-06
WO2006127639A3 (en) 2007-05-18
JP2008545694A (ja) 2008-12-18
ES2358884T3 (es) 2011-05-16
WO2006127639A2 (en) 2006-11-30
ATE492269T1 (de) 2011-01-15
PT1883392E (pt) 2011-03-29
US20060270708A1 (en) 2006-11-30
EP1883392B1 (en) 2010-12-22
CY1111445T1 (el) 2015-08-05
SI1883392T1 (sl) 2011-07-29
DK1883392T3 (da) 2011-04-18

Similar Documents

Publication Publication Date Title
CY1111445T1 (el) Μεθοδος παρασκευης ισοτονης υδατικης ενεσης ροπιβακαϊνης
CA2652529A1 (en) Orthodontic bracket
MY160542A (en) An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
MY138941A (en) Aryl-pyridine derivatives
MX2009001840A (es) Procedimiento para la preparacion de derivados de acido 3-dihalometilpirazol-4-carboxilico.
BR112013014715B8 (pt) processo para produzir um artigo oco polimérico
IN2012DN00765A (pl)
WO2009117150A3 (en) Method of treating lupus with ceramide derivatives
UA107779C2 (en) Method of synthetic 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one and use in the synthesis ivabradynu and its addition salts with pharmaceutically acceptable acid
UY32496A (es) Derivados de n-[(6-aza-biciclo[3.2.1]oct-5-il)-aril-metil]-heterobenzamida, su preparación y su aplicación en terapéutica.
MX2011007006A (es) Sal doble de acido de cefdinir y su preparacion.
BRPI0907999A2 (pt) processo de preparação de combretastatina
MX2011011716A (es) Derivados de isoquinolina novedosos.
CY1116500T1 (el) Μεθοδος ενζυματικης συνθεσης toy (7s)-1-(3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριεν-7-υλ)-ν-μεθυλομεθαναμινης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων αυτης
AR056181A1 (es) Procedimiento para producir nonapeptido leuprolida
JO3054B1 (ar) طريقة تركيب إنزيمي لـ (7 اس) – 3، 4 – ثنائي ميثوكسي سيكلو [4.2.0] أوكتا – 1.3.5 – تريين – 7 – حمض كربوكسيلي أو إستر منه وتطبيقه في تركيب الايفابرادين وأملاح منه
IL207995A (en) Method for producing sulfonylpyrrols in hdac suppressors
AR054873A1 (es) Procedimiento para producir bepromolina
RU2006128805A (ru) Способ получения 3-тиа-1,5-диазабицикло[4,3,1]декана и 5-[4-(1,3,5-дитиазинан-5-ил)бутил]1,3,5-дитиазинана
TW200738605A (en) Process for the production of (alkoxycarbonylamino)alkyl sulfonates
AR053972A1 (es) Procedimiento para produccion de 2 - cloro-4- nitroimidazol
MX2009003640A (es) Derivados de acidos vinilogos como inhibidores de quimasa.
DE602006005655D1 (de) Nazeprilhydrochlorid
CO5640108A2 (es) Derivados de 1-[4-metoxi-7-(morfolin-4-il)-1,3-benzotiazol-2-il]urea
TH100658A (th) การเข้าสูตรเอเควียสโคลซาลปีน